Rhiannon Lassiter

Read more about the article AtlantiCare First in Northeast to Deploy Optellum AI Alongside Robotics for Early Lung Cancer Diagnosis and Treatment

By adopting the Optellum Virtual Nodule Clinic, the Interventional Pulmonology team at AtlantiCare’s Lung Nodule Clinic, led by Amit Borah, M.D., interventional pulmonologist, focuses on identifying and systematically following up on patients with incidentally detected lung nodules.

AtlantiCare First in Northeast to Deploy Optellum AI Alongside Robotics for Early Lung Cancer Diagnosis and Treatment

Post published:February 23, 2023
Post category:News and PR Media Partners

AtlantiCare joined leading healthcare systems worldwide by becoming the first system in the northeastern U.S. to use the Optellum Virtual Nodule Clinic. EGG HARBOR TOWNSHIP, N.J., Feb. 23, 2023 /PRNewswire/ -- AtlantiCare is the…

Jason Pesterfield at the Texas Medical Center

Jason Pesterfield, Optellum CEO, appears on Houston Innovators podcast

Post published:December 23, 2022
Post category:Podcast News and PR

Jason joined the Natalie Harms, the editor of Innovation Map, to talk about Optellum's journey and his career as a serial innovator with roles at Stryker and Veran. "I'm not…

150 most promising digital health companies of 2022, according to CB Insights

Post published:December 7, 2022
Post category:Media

CB Insights, a market research and business analytics firm, has released its annual ranking of the 150 most promising digital health startups, including Optellum. The listed companies have raised $5.6 billion…

Dr Senitko with Senior Research Scientist and Founder Lyndsey Pickup and Research Scientist Noah Waterfield Price

Pulmonary advances and clinical collaborations at CHEST 2022

Post published:November 2, 2022
Post category:Conference

In October 2022, the American College of Chest Physicians (CHEST) held its Annual Meeting in Nashville, Tennessee, and the Optellum team was there to exhibit our innovative technology and attend…

The Optellum team at the 22nd WCBIP/WCBE World Congress. From left to right: Quentin Chometon (Senior Product Manager), Prof. Lutz Freitag MD (Chief Medical Officer), Marco Prattichizzo (Product Manager) and Lewis Lappin (Machine Learning Engineer).

WABIP comes to Europe to showcase the best in lung health

Post published:October 14, 2022
Post category:Conference

Members of the Optellum team gathered in Marseille, alongside clinicians and innovators specialising in lung health, to attend the 22nd WCBIP/WCBE World Congress organised by the World Association of Bronchology…

Read more about the article Optellum, AI Lung Cancer Diagnosis Innovator,<br>Secures $14M Series A Funding to Accelerate Expansion

Optellum, AI Lung Cancer Diagnosis Innovator,
Secures $14M Series A Funding to Accelerate Expansion

Post published:September 27, 2022
Post category:Investment Media News and PR

Lead investor Mercia, alongside Intuitive Ventures and Black Opal, invests inOptellum’s pioneering AI-powered lung-health technology Oxford, 27 September 2022, 8am: Optellum, an Oxford-based medtech company that provides a breakthrough AI…

Read more about the article Artificial Intelligence is playing a critical role in transforming patient care at the American Association for Bronchology and Interventional Pulmonology 5th annual conference

Artificial Intelligence is playing a critical role in transforming patient care at the American Association for Bronchology and Interventional Pulmonology 5th annual conference

Post published:August 29, 2022
Post category:Event Conference

Once a year, the American Association for Bronchology and Interventional Pulmonology gather the bright minds of innovators and industry experts working in pulmonology and thoracic care to meet and share…

Optellum research highlighted at the IASLC World Conference on Lung Cancer

Post published:August 20, 2022
Post category:Conference Event

The International Association for the Study of Lung Cancer (IASLC) hosted its annual conference in Vienna, Austria and the Optellum team were glad to be amongst attendees and exhibitors,highlighting the…

Optellum shows neural networks can robustly quantify emphysema from CT images

Post published:August 16, 2022
Post category:Clinical

At the recent American Thoracic Society (ATS) annual meeting, Dr Michael Gregory Lester MD and Dr Fabien Maldonado MD, of Vanderbilt University Medical Centre, presented a poster ‘Utilizing a Deep…

World lung cancer day badge

How Optellum is working to change the survival rates for lung cancer with an innovative AI platform

Post published:August 1, 2022
Post category:News and PR

Optellum was founded with the vision of providing clinical decision support software that could help lung disease patients be diagnosed and treated with curative intent at the earliest possible stage.…

Optellum team members (left to right): Dr Lyndsey Pickup PhD, Dr Elnaz Gederi PhD and Dr Aydan Gasimova PhD, at ESTI 2022.

Optellum welcomes ESTI back to Oxford for 2022 congress

Post published:June 30, 2022
Post category:Conference

In June 2022, the European Society of Thoracic Imaging (ESTI) held its first in-person annual scientific meeting since the pandemic. Optellum were fortunate to have the meeting on our doorstep,…

PRESS RELEASE: CMS assigns new technology payment classification for Optellum’s Lung Cancer Prediction score

Post published:June 28, 2022
Post category:Media News and PR Regulatory

This payment assignment to a newly available Healthcare Common Procedure Coding System (HCPCS) code constitutes an important step towards reimbursing providers for the use of Optellum’s transformative technology with Medicare…